2,018,508 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Two Sigma Investments LP

Two Sigma Investments LP purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,018,508 shares of the health services provider's stock, valued at approximately $18,348,000. Two Sigma Investments LP owned 1.17% of Teladoc Health as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Robeco Institutional Asset Management B.V. lifted its stake in shares of Teladoc Health by 21.8% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after acquiring an additional 125,111 shares during the period. Nisa Investment Advisors LLC increased its stake in shares of Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after acquiring an additional 424,180 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in Teladoc Health by 18.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after purchasing an additional 384,528 shares in the last quarter. Geode Capital Management LLC lifted its position in Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares during the period. Finally, Commonwealth Equity Services LLC lifted its position in Teladoc Health by 35.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock valued at $1,032,000 after purchasing an additional 29,903 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have issued reports on TDOC shares. Bank of America dropped their target price on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Canaccord Genuity Group dropped their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Jefferies Financial Group cut their price objective on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Citigroup decreased their target price on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research report on Friday, April 25th. Finally, Stifel Nicolaus cut their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, Teladoc Health currently has an average rating of "Hold" and an average target price of $9.71.

Teladoc Health Trading Down 0.9%

Shares of TDOC opened at $6.91 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -1.20 and a beta of 1.82. The firm has a 50 day simple moving average of $7.45 and a 200-day simple moving average of $9.31.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.58% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.